161 related articles for article (PubMed ID: 36838242)
1. Diversity and Comparison of Intestinal
Lu G; Zhang Y; Ren Y; Shi JS; Xu ZH; Geng Y
Microorganisms; 2023 Jan; 11(2):. PubMed ID: 36838242
[No Abstract] [Full Text] [Related]
2.
Wan YY; Luo N; Liu XL; Lai QL; Goodfellow M
Int J Syst Evol Microbiol; 2021 Feb; 71(2):. PubMed ID: 33406030
[TBL] [Abstract][Full Text] [Related]
3. Toxicity of hydrogen sulfide toward sulfate-reducing bacteria Desulfovibrio piger Vib-7.
Kushkevych I; Dordević D; Vítězová M
Arch Microbiol; 2019 Apr; 201(3):389-397. PubMed ID: 30707247
[TBL] [Abstract][Full Text] [Related]
4. Isolation of Desulfovibrio spp. from human gut microbiota using a next-generation sequencing directed culture method.
Chen YR; Zhou LZ; Fang ST; Long HY; Chen JY; Zhang GX
Lett Appl Microbiol; 2019 Jun; 68(6):553-561. PubMed ID: 30835854
[TBL] [Abstract][Full Text] [Related]
5. Isolation and evaluation of susceptibility to sulphasalazine of Desulfovibrio desulfuricans strains from the human digestive tract.
Dzierzewicz Z; Cwalina B; Gawlik B; Wilczok T; Gonciarz Z
Acta Microbiol Pol; 1997; 46(2):175-87. PubMed ID: 9429289
[TBL] [Abstract][Full Text] [Related]
6. Metabolic niche of a prominent sulfate-reducing human gut bacterium.
Rey FE; Gonzalez MD; Cheng J; Wu M; Ahern PP; Gordon JI
Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13582-7. PubMed ID: 23898195
[TBL] [Abstract][Full Text] [Related]
7. Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases.
Loubinoux J; Bronowicki JP; Pereira IA; Mougenel JL; Faou AE
FEMS Microbiol Ecol; 2002 May; 40(2):107-12. PubMed ID: 19709217
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Desulfovibrio desulfuricans intestinal strains to sulfasalazine and its biotransformation products.
Dzierzewicz Z; Cwalina B; Weglarz L; Wiśniowska B; Szczerba J
Med Sci Monit; 2004 Jun; 10(6):BR185-90. PubMed ID: 15173665
[TBL] [Abstract][Full Text] [Related]
9. Arsenic thiolation and the role of sulfate-reducing bacteria from the human intestinal tract.
D C Rubin SS; Alava P; Zekker I; Du Laing G; Van de Wiele T
Environ Health Perspect; 2014 Aug; 122(8):817-22. PubMed ID: 24833621
[TBL] [Abstract][Full Text] [Related]
10. Biocorrosion of Endodontic Files through the Action of Two Species of Sulfate-reducing Bacteria: Desulfovibrio desulfuricans and Desulfovibrio fairfieldensis.
Heggendorn FL; Gonçalves LS; Dias EP; de Oliveira Freitas Lione V; Lutterbach MT
J Contemp Dent Pract; 2015 Aug; 16(8):665-73. PubMed ID: 26423503
[TBL] [Abstract][Full Text] [Related]
11. Biochemical differentiation and comparison of Desulfovibrio species and other phenotypically similar genera.
Warren YA; Citron DM; Merriam CV; Goldstein EJ
J Clin Microbiol; 2005 Aug; 43(8):4041-5. PubMed ID: 16081948
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen Sulfide as a Toxic Product in the Small-Large Intestine Axis and its Role in IBD Development.
Kushkevych I; Dordević D; Kollar P; Vítězová M; Drago L
J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31330956
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Sulfate Reduction and Cell Division by Desulfovibrio desulfuricans Coated in Palladium Metal.
Barnes RJ; Voegtlin SP; Naik SR; Gomes R; Hubert CRJ; Larter SR; Bryant SL
Appl Environ Microbiol; 2022 Jun; 88(12):e0058022. PubMed ID: 35638843
[TBL] [Abstract][Full Text] [Related]
14. Chondroitin sulfate stimulates the secretion of H
Chen L; Gao Y; Zhao Y; Yang G; Wang C; Zhao Z; Li S
Int J Biol Macromol; 2022 Jul; 213():631-638. PubMed ID: 35667460
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity.
Lin YC; Lin HF; Wu CC; Chen CL; Ni YH
J Gastroenterol; 2022 Nov; 57(11):913-925. PubMed ID: 35976494
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Physiological Parameters of
Kushkevych I; Dordević D; Kollár P
Open Life Sci; 2018 Jan; 13():481-488. PubMed ID: 33817117
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Physiological Parameters of Intestinal Sulfate-Reducing Bacteria Isolated from Patients Suffering from IBD and Healthy People.
Kushkevych I; Castro Sangrador J; Dordević D; Rozehnalová M; Černý M; Fafula R; Vítězová M; Rittmann SKR
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32575467
[TBL] [Abstract][Full Text] [Related]
18. Growth-promoting effects of the hydrogen-sulfide compounds produced by Desulfovibrio desulfuricans subsp. desulfuricans co-cultured with Escherichia coli (DH5α) on the growth of Entamoeba and Endolimax species isolates from swine.
Yoshida N; Kobayashi S; Suzuki J; Azuma Y; Kobayashi-Ogata N; Kartikasari DP; Yanagawa Y; Iwata S
Biosci Trends; 2019 Nov; 13(5):402-410. PubMed ID: 31597818
[TBL] [Abstract][Full Text] [Related]
19. First isolation of Desulfovibrio from the human vaginal flora.
Ichiishi S; Tanaka K; Nakao K; Izumi K; Mikamo H; Watanabe K
Anaerobe; 2010 Jun; 16(3):229-33. PubMed ID: 20159048
[TBL] [Abstract][Full Text] [Related]
20. NADH and NADPH peroxidases as antioxidant defense mechanisms in intestinal sulfate-reducing bacteria.
Kushkevych I; Dordević D; Alberfkani MI; Gajdács M; Ostorházi E; Vítězová M; Rittmann SKR
Sci Rep; 2023 Aug; 13(1):13922. PubMed ID: 37626119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
